COVID-19 New Cases 506... Over 500 for the First Time in Four Days (Update)

250,000 doses (500,000 shots) of the U.S. Pfizer COVID-19 vaccine, intended for vaccination of seniors aged 75 and older and residents and workers of elderly care facilities, are arriving at Incheon International Airport Cargo Terminal on the 31st. Photo by Moon Honam munonam@

[Asia Economy Reporter Seo So-jeong] The number of new domestic COVID-19 cases has risen to the 500s for the first time in four days.

The Central Disease Control Headquarters (CDCH) announced on the 31st at midnight that there were 506 new domestic COVID-19 cases, bringing the total to 103,088.

Among them, 491 cases were domestic transmissions, and 15 were imported cases.

By region, Seoul reported 156 cases, Gyeonggi 106, and Incheon 25, with the metropolitan area totaling 287 cases, accounting for 58.5% of all domestic cases.

In non-metropolitan areas, cases surged with Busan reporting 58, Chungbuk and Gyeongnam 21, Jeonbuk 20, Sejong 17, Gangwon 16, Daegu 15, Ulsan 11, Chungnam 8, Daejeon 7, Gyeongbuk 6, and Gwangju and Jeju 2 each. No cases were reported in Jeonnam.

Of the 15 imported cases, 7 were detected during quarantine, and the remaining 8 were confirmed within the local community. Ten were Korean nationals, and five were foreigners.

The number of critically ill patients is 108, and the death toll increased by 2 the previous day, bringing the total deaths to 1,731. The number of newly released from isolation increased by 467, totaling 95,030.

The number of suspected cases tested was 43,801, and 32,975 tests were conducted at temporary screening clinics set up in the metropolitan area, with 94 confirmed positive. The total number of tests conducted was 76,776.

Meanwhile, according to the COVID-19 Vaccination Response Promotion Team, as of midnight on the same day, 28,407 people received COVID-19 vaccinations, bringing the total first-dose recipients to 852,202. The number of new second-dose vaccinations was 2,034, with a total of 8,185 people having completed the second dose.

Among the vaccines, 791,454 doses of the AstraZeneca vaccine and 60,748 doses of the Pfizer vaccine were administered.

The number of suspected adverse reactions reported after COVID-19 vaccination increased by 90 cases the previous day, totaling 10,575 cases.

Newly reported cases included 4 deaths, 1 suspected anaphylaxis, and 3 suspected severe cases.

Of the 90 cases, 82 were common post-vaccination symptoms such as muscle pain, headache, fever, chills, and nausea.

This content was produced with the assistance of AI translation services.